Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: Echocardiographic and tissue Doppler imaging assessment

被引:138
作者
Goland, Sorel
Shimoni, Sara
Zornitzki, Taiba
Knobler, Hilla
Azoulai, Orly
Lutaty, Gaby
Melzer, Ehud
Orr, Ayella
Caspi, Avraham
Malnick, Stephen [1 ]
机构
[1] Hebrew Univ Jerusalem, Kapiolani Med Ctr, Dept Internal Med C, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Kapiolani Med Ctr, Inst Heart, IL-76100 Rehovot, Israel
[3] Hebrew Univ Jerusalem, Kapiolani Med Ctr, Endocrine Unit, IL-76100 Rehovot, Israel
[4] Hebrew Univ Jerusalem, Kapiolani Med Ctr, Gastroenterol Inst, IL-76100 Rehovot, Israel
关键词
metabolic syndrome; nonalcoholic fatty liver disease; LV diastolic dysfunction;
D O I
10.1097/01.mcg.0000225668.53673.e6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is linked to the metabolic syndrome. The aim of the present study is to determine the effect of the metabolic syndrome on left ventricular (LV) geometry and function using as a model patients with NAFLD. Thirty-eight patients with NAFLD, less than 55 years of age and with a normal exercise test, were compared with an age and sex-matched control group. Patients with diabetes mellitus, hypertension, and body mass index > 40 were excluded. A complete echocardiographic study including tissue Doppler imaging (TDI) was performed. The following parameters were assessed by echo Doppler: peak velocities of early (E) and late (A) diastolic filling, E/A ratio, flow propagation velocity (V-p). Using TDI early diastolic velocity (E'),. and systolic velocity (Y) of mitral annulus were obtained. The patients with NAFLD had a significantly higher body mass (100.6 +/- 13 vs. 83.0 +/- 10 mg/dL, P = 0.01), and triglyceride levels (126.5 +/- 44 vs. 206.5 +/- 67 mg/dL, P < 0.00 1). Increased thickness of the intraventricular septum, posterior wall (11.03 +/- 2.2 vs. 8.9 +/- 2.9 mm, P = 0.00 1; 8.5 +/- 1.7 vs. 9.7 +/- 2.3 mm, P = 0.04), and larger LV mass and LV mass/ height (160.7 +/- 58.7 vs. 115.3 +/- 3 5.4 g, P = 0.001 and 92.6 +/- 29.5 vs. 69.2 +/- 19.8 g/m,. P = 0.00 1, respectively) were found in NAFLD group. LV systolic function was similar in both groups. Patients with NAFLD had a lower E (73.6 +/- 11.0 vs. 86.4 +/- 20.0 cm/s, P < 0.006) and E/A ratio (1.0 +/- 0.3 vs. 1.76 +/- 0.8 P < 0.0001). Moreover, the V-p and the E' on TDI were significantly lower compared with the control group (49.0 +/- 9.7 vs. 74.7 +/- 18.4 cm/s, P < 0.0001 and 10.3 +/- 2.0 vs. 13.8 +/- 1.7 cm/s. P < 0.000 1 respectively). On multivariate analysis the E' on TDI was the only independent parameter associated with NAFLD. In conclusion, patients with NAFLD in the absence of morbid obesity, hypertension, and diabetes have mildly altered LV geometry and early features of left ventricular diastolic dysfunction. Early diastolic velocity on TDI was found to be the only index that could identify the patients with NAFLD and metabolic syndrome.
引用
收藏
页码:949 / 955
页数:7
相关论文
共 41 条
[1]   NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[2]   IS HEPATIC ULTRASONOGRAPHY A VALID ALTERNATIVE TOOL TO LIVER-BIOPSY - REPORT ON 507 CASES STUDIED WITH BOTH TECHNIQUES [J].
CELLE, G ;
SAVARINO, V ;
PICCIOTTO, A ;
MAGNOLIA, MR ;
SCALABRINI, P ;
DODERO, M .
DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (04) :467-471
[3]   Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (The Strong Heart study) [J].
Chinali, M ;
Devereux, RB ;
Howard, BV ;
Roman, MJ ;
Bella, JN ;
Liu, JE ;
Resnick, HE ;
Lee, ET ;
Best, LG ;
de Simone, G .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (01) :40-44
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]   Nonalcoholic fatty liver disease [J].
Clark, JM ;
Brancati, FL ;
Diehl, AM .
GASTROENTEROLOGY, 2002, 122 (06) :1649-1657
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Insulin resistance in non-alcoholic steatohepatitis [J].
Cömert, B ;
Mas, MR ;
Erdem, H ;
Dinc, A ;
Saglamkaya, U ;
Cigerim, M ;
Kuzhan, O ;
Unal, T ;
Kocabalkan, F .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (04) :353-358
[8]   Insulin resistance syndrome and left ventricular mass in healthy young people [J].
Davis, CL ;
Kapuku, G ;
Snieder, H ;
Kumar, M ;
Treiber, FA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 324 (02) :72-75
[9]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[10]   Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance [J].
Dutta, R ;
Podolin, DA ;
Davidson, MB ;
Davidoff, AJ .
DIABETES, 2001, 50 (05) :1186-1192